Title : Neoadjuvant weekly paclitaxel with and without trastuzumab in locally advanced or metastatic breast cancer.

Pub. Date : 2009 Feb

PMID : 19331197






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In conclusion, combined neoadjuvant weekly paclitaxel and trastuzumab achieved high clinical and pathological response rates for HER2 -overexpressing breast cancers, despite the omission of an anthracycline. Paclitaxel erb-b2 receptor tyrosine kinase 2 Homo sapiens